The National Rugby League has today imposed a two-year suspension on Manly Under 20’s player Shane Gray over a positive test to Clenbuterol, which is classed as an anabolic agent.
The positive sample was collected in an Australian Sports Anti-Doping Authority out of competition test during June 2009 and confirmed through subsequent sample analysis by the ASADA.
Mr Gray has elected not to contest the matter before a hearing and accepted the two-year sanction under the World Anti-Doping Agency Code.
He has made it clear that he has at no time sought to deliberately break the WADA code and remains unaware as to how the substance entered his system.
Mr Gray has been provisionally suspended since June 18, 2009 and will next be eligible to play on June 19, 2011.
Note: Clenbuterol is prohibited both in and out of competition under the World Anti-Doping Authority Code 2009 Prohibited List S1 (2). A finding of a doping offence in relation to the presence of this substance in an athlete’s sample would see an athlete face a two-year penalty subject only to that athlete arguing a reduction through the ameliorating provisions within the policy including the ‘No Significant Fault or Negligence’ clause (to do so the athlete needs be able to show how the substance entered his/her system) or through providing substantial assistance in ‘Discovering or Establishing Anti-Doping Rule Violations’.